Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland

被引：131
作者：
Lewis, Aaron G. [1 ]
Tong, Tommy [2 ]
Maghami, Ellie [3 ]
机构：
[1] City Hope Natl Med Ctr, Dept Surg, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Pathol, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Div Head & Neck Surg, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2016年 / 49卷 / 02期
关键词：
Parotid cancer; Malignant salivary cancers; Surgery for parotid salivary cancer; Radiation therapy for parotid cancers; Chemotherapy for parotid tumors; Molecular diagnostics; Genetic translocations of parotid tumors; Molecular targeted therapies; ADENOID CYSTIC CARCINOMA; GROWTH-FACTOR RECEPTOR; ANALOG SECRETORY CARCINOMA; LYMPH-NODE METASTASIS; MUCOEPIDERMOID CARCINOMA; RADIATION-THERAPY; PHASE-II; ANDROGEN RECEPTOR; C-KIT; DIFFERENTIAL-DIAGNOSIS;
D O I：
10.1016/j.otc.2015.11.001
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Malignant parotid tumors are heterogeneous and diverse. Accurate diagnosis requires a pathologist familiar with the various histologic sub-types, immunohistochemistry stains, and common translocations. Clinical course varies according to tumor subtype, ranging from indolent, slow growing adenoid cystic carcinoma to rapidly progressive, often fatal, salivary ductal carcinoma. Histologic grade is important in prognosis and therapy. Surgery remains the mainstay of treatment when negative margins can be achieved. Radiation improves locoregional control of tumors with high-risk features. Chemotherapy for parotid tumors can be disappointing. Studies of new targeted therapies have not offered significant benefits.
引用
收藏
页码：343 / +
页数：39
相关论文
共 137 条
[91]   Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections [J].
Nordgard, S ;
Franzen, G ;
Boysen, M ;
Halvorsen, TB .
LARYNGOSCOPE, 1997, 107 (04) :531-536
[92]   Frozen Section Pathology for Decision Making in Parotid Surgery [J].
Olsen, Kerry D. ;
Moore, Eric J. ;
Lewis, Jean E. .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2013, 139 (12) :1275-1278
[93]   Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies [J].
Pederson, Aaron W. ;
Salama, Joseph K. ;
Haraf, Daniel J. ;
Witt, Mary Ellen ;
Stenson, Kerstin M. ;
Portugal, Louis ;
Seiwert, Tanguy ;
Villaflor, Victoria M. ;
Cohen, Ezra E. W. ;
Vokes, Everett E. ;
Blair, Elizabeth A. .
HEAD & NECK ONCOLOGY, 2011, 3
[94]   Chemoreirradiation for recurrent salivary gland malignancies [J].
Pederson, Aaron W. ;
Haraf, Daniel J. ;
Blair, Elizabeth A. ;
Stenson, Kerstin M. ;
Witt, Mary-Ellyn ;
Yokes, Everett E. ;
Salama, Joseph K. .
RADIOTHERAPY AND ONCOLOGY, 2010, 95 (03) :308-311
[95]   Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck [J].
Persson, Marta ;
Andren, Ywonne ;
Mark, Joachim ;
Horlings, Hugo M. ;
Persson, Fredrik ;
Stenman, Goran .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (44) :18740-18744
[96]   Diagnostic value of ultrasound-guided core needle biopsy in patients with salivary gland masses [J].
Pfeiffer, J. ;
Ridder, G. J. .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2012, 41 (04) :437-443
[97]   Mammary analog secretory carcinoma of salivary gland: Cytologic diagnosis and differential diagnosis of an unreported entity [J].
Pisharodi, Latha .
DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (03) :239-241
[98]   Salivary duct carcinoma of the parotid [J].
Pons, Y. ;
Alves, A. ;
Clement, P. ;
Conessa, C. .
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2011, 128 (04) :194-196
[99]  
Qureshi Sajid S, 2005, Indian J Gastroenterol, V24, P29
[100]   Positron Emission Tomography-Computed Tomography Adds to the Management of Salivary Gland Malignancies [J].
Razfar, Ali ;
Heron, Dwight E. ;
Branstetter, Barton F. ;
Seethala, Raja R. ;
Ferris, Robert L. .
LARYNGOSCOPE, 2010, 120 (04) :734-738
567891011121314